Jun 11, 2026 08:41AM
Jun 11, 2026 08:41AM
May 28, 2026 07:00AM
Apr 20, 2026 05:00PM
Apr 20, 2026 05:00PM
Apr 19, 2026 10:00AM
Mar 30, 2026 07:01AM KalVista reports interim Phase 3 data for pediatric HAE treatment
Mar 30, 2026 07:00AM
Feb 18, 2026 07:00AM
Feb 18, 2026 07:00AM
Jan 7, 2026 06:30PM
Sep 11, 2025 07:02AM
Sep 11, 2025 07:00AM
Jul 25, 2025 08:00AM KalVista gets positive EU opinion for hereditary angioedema drug
Jul 25, 2025 08:00AM
Jul 15, 2025 04:05PM
Jul 15, 2025 04:05PM
Jul 11, 2025 06:37AM
Jul 10, 2025 10:29AM
Jul 10, 2025 07:00AM
Jul 7, 2025 02:40PM Kalvista Pharmaceuticals Inc (KALV) PT Raised to $20 at Leerink Partners
Jul 7, 2025 06:31AM
Jul 7, 2025 06:30AM
Jul 2, 2025 04:05PM
Jun 26, 2025 07:02AM
Jun 26, 2025 07:00AM
Jun 24, 2025 03:50PM
Jun 24, 2025 01:57PM KalVista Pharmaceuticals (KALV) falls after FDA chief said to have sought rejection of drug
Jun 16, 2025 07:28AM
Jun 16, 2025 07:03AM
Jun 16, 2025 07:00AM
Jun 16, 2025 04:19AM
Jun 13, 2025 04:06PM
Jun 13, 2025 04:05PM
Jun 5, 2025 07:00AM KalVista Pharmaceuticals to Present New Sebetralstat Data at the European Academy of Allergy and Clinical Immunology Congress 2025
Jun 3, 2025 04:01PM
Jun 2, 2025 07:00AM
May 29, 2025 07:00AM
May 22, 2025 07:00AM
May 2, 2025 07:00AM
Apr 30, 2025 07:00AM
Apr 8, 2025 06:31AM KalVista Pharmaceuticals (KALV) Enters Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
Apr 8, 2025 06:30AM
Apr 2, 2025 07:00AM
Mar 31, 2025 07:00AM
Mar 25, 2025 07:02AM
Mar 25, 2025 07:00AM
Mar 12, 2025 07:00AM
Mar 10, 2025 07:00AM KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema
Mar 4, 2025 07:00AM

323,454 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All